Date: 21 Feb 2023 to 23 Feb 2023

11th Alzheimer’s and Parkinson’s Drug Development Summit

Venue: Hyatt Centric Fisherman's Wharf San Francisco, 555 North Point Street, San Francisco, California, 94133, United States


Event Notes:

With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals from Biogen, Eisai, and Denali Therapeutics, 2022 has put neurodegenerative drug development back on the map.

Building on the field’s momentum, we are delighted to bring back the 11th Alzheimer’s and Parkinson’s Drug Development Summit, dedicated to overcoming the translational challenges of targeting neurodegenerative mechanisms. This summit will unite neurodegenerative biopharma experts from discovery, preclinical, translational, and clinical backgrounds to showcase the latest breakthroughs in Alzheimer’s, Parkinson’s, and related neurological disorders in 2022 and 2023.

Time: 09:00 – 17:30